IEEE/ACM Transactions on Computational Biology and Bioinformatics最新文献

MiRNAs play an important role in the occurrence and development of human disease. Identifying potential miRNA-disease associations is valuable for disease diagnosis and treatment. Therefore, it is urgent to develop efficient computational methods for predicting potential miRNA-disease associations to reduce the cost and time associated with biological wet experiments. In addition, high-quality feature representation remains a challenge for miRNA-disease association prediction using graph neural network methods. In this paper, we propose a method named ESGC-MDA, which employs an enhanced Simple Graph Convolution Network to identify miRNA-disease associations. We first construct a bipartite attributed graph for miRNAs and diseases by computing multi-source similarity. Then, we enhance the feature representations of miRNA and disease nodes by applying two strategies in the simple convolution network, which include randomly dropping messages during propagation to ensure the model learns more reliable feature representations, and using adaptive weighting to aggregate features from different layers. Finally, we calculate the prediction scores of miRNA-disease pairs by using a fully connected neural network decoder. We conduct 5-fold cross-validation and 10-fold cross-validation on HDMM v2.0 and HMDD v3.2, respectively, and ESGC-MDA achieves better performance than state-of-the-art baseline methods. The case studies for cardiovascular disease, lung cancer and colon cancer also further confirm the effectiveness of ESGC-MDA. The source codes are available at https://github.com/bixuehua/ESGC-MDA.

The stage prediction of kidney renal clear cell carcinoma (KIRC) is important for the diagnosis, personalized treatment, and prognosis of patients. Many prediction methods have been proposed, but most of them are based on unimodal gene data, and their accuracy is difficult to further improve. Therefore, we propose a novel multi-weighted dynamic cascade forest based on the bilinear feature extraction (MLW-BFECF) model for stage prediction of KIRC using multimodal gene datasets (RNA-seq, CNA, and methylation). The proposed model utilizes a dynamic cascade framework with shuffle layers to prevent early degradation of the model. In each cascade layer, a voting technique based on three gene selection algorithms is first employed to effectively retain gene features more relevant to KIRC and eliminate redundant information in gene features. Then, two new bilinear models based on the gated attention mechanism are proposed to better extract new intra-modal and inter-modal gene features; Finally, based on the idea of the bagging, a multi-weighted ensemble forest classifiers module is proposed to extract and fuse probabilistic features of the three-modal gene data. A series of experiments demonstrate that the MLW-BFECF model based on the three-modal KIRC dataset achieves the highest prediction performance with an accuracy of 88.92%.

Protein-protein interactions (PPIs) are essential to understanding cellular mechanisms, signaling networks, disease processes, and drug development, as they represent the physical contacts and functional associations between proteins. Recent advances have witnessed the achievements of artificial intelligence (AI) methods aimed at predicting PPIs. However, these approaches often handle the intricate web of relationships and mechanisms among proteins, drugs, diseases, ribonucleic acid (RNA), and protein structures in a fragmented or superficial manner. This is typically due to the limitations of non-end-to-end learning frameworks, which can lead to sub-optimal feature extraction and fusion, thereby compromising the prediction accuracy. To address these deficiencies, this paper introduces a novel end-to-end learning model, the Knowledge Graph Fused Graph Neural Network (KGF-GNN). This model comprises three integral components: (1) Protein Associated Network (PAN) Construction: We begin by constructing a PAN that extensively captures the diverse relationships and mechanisms linking proteins with drugs, diseases, RNA, and protein structures. (2) Graph Neural Network for Feature Extraction: A Graph Neural Network (GNN) is then employed to distill both topological and semantic features from the PAN, alongside another GNN designed to extract topological features directly from observed PPI networks. (3) Multi-layer Perceptron for Feature Fusion: Finally, a multi-layer perceptron integrates these varied features through end-to-end learning, ensuring that the feature extraction and fusion processes are both comprehensive and optimized for PPI prediction. Extensive experiments conducted on real-world PPI datasets validate the effectiveness of our proposed KGF-GNN approach, which not only achieves high accuracy in predicting PPIs but also significantly surpasses existing state-of-the-art models. This work not only enhances our ability to predict PPIs with a higher precision but also contributes to the broader application of AI in Bioinformatics, offering profound implications for biological research and therapeutic development.

Machine learning algorithms have been extensively used for accurate classification of cancer subtypes driven by gene expression-based biomarkers. However, biomarker models combining multiple gene expression signatures are often not reproducible in external validation datasets and their feature set size is often not optimized, jeopardizing their translatability into cost-effective clinical tools. We investigated how to solve the multi-objective problem of finding the best trade-offs between classification performance and set size applying seven algorithms for machine learning-driven feature subset selection and analyse how they perform in a benchmark with eight large-scale transcriptome datasets of cancer, covering both training and external validation sets. The benchmark includes evaluation metrics assessing the performance of the individual biomarkers and the solution sets, according to their accuracy, diversity, and stability of the composing genes. Moreover, a new evaluation metric for cross-validation studies is proposed that generalizes the hypervolume, which is commonly used to assess the performance of multi-objective optimization algorithms. Biomarkers exhibiting 0.8 of balanced accuracy on the external dataset for breast, kidney and ovarian cancer using respectively 4, 2 and 7 features, were obtained. Genetic algorithms often provided better performance than other considered algorithms, and the recently proposed NSGA2-CH and NSGA2-CHS were the best performing methods in most cases.

Currently, biomedical event extraction has received considerable attention in various fields, including natural language processing, bioinformatics, and computational biomedicine. This has led to the emergence of numerous machine learning and deep learning models that have been proposed and applied to tackle this complex task. While existing models typically adopt an extraction-based approach, which requires breaking down the extraction of biomedical events into multiple subtasks for sequential processing, making it prone to cascading errors. This paper presents a novel approach by constructing a biomedical event generation model based on the framework of the pre-trained language model T5. We employ a sequence-tosequence generation paradigm to obtain events, the model utilizes constrained decoding algorithm to guide sequence generation, and a curriculum learning algorithm for efficient model learning. To demonstrate the effectiveness of our model, we evaluate it on two public benchmark datasets, Genia 2011 and Genia 2013. Our model achieves superior performance, illustrating the effectiveness of generative modeling of biomedical events.

Hi-C experiments allow researchers to study and understand the 3D genome organization and its regulatory function. Unfortunately, sequencing costs and technical constraints severely restrict access to high-quality Hi-C data for many cell types. Existing frameworks rely on a sparse Hi-C dataset or cheaper-to-acquire ChIP-seq data to predict Hi-C contact maps with high read coverage. However, these methods fail to generalize to sparse or cross-cell-type inputs because they do not account for the contributions of epigenomic features or the impact of the structural neighborhood in predicting Hi-C reads. We propose GrapHiC, which combines Hi-C and ChIP-seq in a graph representation, allowing more accurate embedding of structural and epigenomic features. Each node represents a binned genomic region, and we assign edge weights using the observed Hi-C reads. Additionally, we embed ChIP-seq and relative positional information as node attributes, allowing our representation to capture structural neighborhoods and the contributions of proteins and their modifications for predicting Hi-C reads. We show that GrapHiC generalizes better than the current state-of-the-art on cross-cell-type settings and sparse Hi-C inputs. Moreover, we can utilize our framework to impute Hi-C reads even when no Hi-C contact map is available, thus making high-quality Hi-C data accessible for many cell types. Availability: https://github.com/rsinghlab/GrapHiC.

Generating high-quality and drug-like molecules from scratch within the expansive chemical space presents a significant challenge in the field of drug discovery. In prior research, value-based reinforcement learning algorithms have been employed to generate molecules with multiple desired properties iteratively. The immediate reward was defined as the evaluation of intermediate-state molecules at each step, and the learning objective would be maximizing the expected cumulative evaluation scores for all molecules along the generative path. However, this definition of the reward was misleading, as in reality, the optimization target should be the evaluation score of only the final generated molecule. Furthermore, in previous works, randomness was introduced into the decision-making process, enabling the generation of diverse molecules but no longer pursuing the maximum future rewards. In this paper, immediate reward is defined as the improvement achieved through the modification of the molecule to maximize the evaluation score of the final generated molecule exclusively. Originating from the A ∗ search, path consistency (PC), i.e., f values on one optimal path should be identical, is employed as the objective function in the update of the f value estimator to train a multi-objective de novo drug designer. By incorporating the f value into the decision-making process of beam search, the DrugBA∗ algorithm is proposed to enable the large-scale generation of molecules that exhibit both high quality and diversity. Experimental results demonstrate a substantial enhancement over the state-of-theart algorithm QADD in multiple molecular properties of the generated molecules.

Three-dimensional (3D) reconstruction in single-particle cryo-electron microscopy (cryo-EM) is a critical technique for recovering and studying the fine 3D structure of proteins and other biological macromolecules, where the primary issue is to determine the orientations of projection images with high levels of noise. This paper proposes a method to determine the orientations of cryo-EM projection images using reliable common lines and spherical embeddings. First, the reliability of common lines between projection images is evaluated using a weighted voting algorithm based on an iterative improvement technique and binarized weighting. Then, the reliable common lines are used to calculate the normal vectors and local X-axis vectors of projection images after two spherical embeddings. Finally, the orientations of projection images are determined by aligning the results of the two spherical embeddings using an orthogonal constraint. Experimental results on both synthetic and real cryo-EM projection image datasets demonstrate that the proposed method can achieve higher accuracy in estimating the orientations of projection images and higher resolution in reconstructing preliminary 3D structures than some common line-based methods, indicating that the proposed method is effective in single-particle cryo-EM 3D reconstruction.